SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES) in a report released on Friday. The firm issued a sell rating on the stock.

Separately, HC Wainwright reissued a buy rating and set a $35.00 target price on shares of SenesTech in a report on Tuesday, May 14th.

SenesTech Trading Down 2.0 %

SenesTech stock opened at $3.00 on Friday. SenesTech has a 12 month low of $2.65 and a 12 month high of $78.00. The company has a current ratio of 4.68, a quick ratio of 3.49 and a debt-to-equity ratio of 0.05. The business’s 50 day simple moving average is $4.33 and its 200 day simple moving average is $6.30.

SenesTech (NASDAQ:SNES) last issued its earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The business had revenue of $0.46 million for the quarter, compared to analysts’ expectations of $0.49 million. During the same quarter in the previous year, the firm posted ($84.03) EPS. As a group, research analysts expect that SenesTech will post -11 EPS for the current fiscal year.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.